Clinical Trials Directory

Trials / Conditions / Hyper-IgM Syndrome

Hyper-IgM Syndrome

4 registered clinical trials studyying Hyper-IgM Syndrome.

StatusTrialSponsorPhase
CompletedBioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex
NCT01963143
Bio Products LaboratoryPhase 3
Active Not RecruitingAllogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
NCT01652092
Masonic Cancer Center, University of MinnesotaN/A
CompletedA Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency
NCT01289847
Bio Products LaboratoryPhase 4
TerminatedStudies of Disorders in Antibody Production and Related Primary Immunodeficiency States
NCT00266513
National Institute of Allergy and Infectious Diseases (NIAID)—